Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
Autorzy:
Benzaquen J; Department of Pulmonary Medicine and Thoracic Oncology, Nice University Hospital, Pasteur Hospital, FHU OncoAge, Côte d'Azur University, 30, Voie Romaine, 06000, Nice, France. .; CNRS, INSERM, Institute of Research On Cancer and Aging, Côte d'Azur University, Nice, France. . BondiauPY; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France. Otto J; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France. Marquette CH; Department of Pulmonary Medicine and Thoracic Oncology, Nice University Hospital, Pasteur Hospital, FHU OncoAge, Côte d'Azur University, 30, Voie Romaine, 06000, Nice, France.; CNRS, INSERM, Institute of Research On Cancer and Aging, Côte d'Azur University, Nice, France. Berthet JP; Department of Thoracic Surgery, Nice University Hospital, Pasteur Hospital, Nice, France. Naghavi AO; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Schiappa R; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France. Hannoun-Levi JM; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France. Padovani B; Department of Radiology, Nice University Hospital, Côte d'Azur University, Nice, France. Doyen J; CNRS, INSERM, Institute of Research On Cancer and Aging, Côte d'Azur University, Nice, France.; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France.
Long-term hospitalisations in survivors of paediatric solid tumours in France.
Autorzy:
Bejarano-Quisoboni D; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Primary care and Prevention Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Pelletier-Fleury N; Primary care and Prevention Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France. Allodji RS; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Fresneau B; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France.; Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, France. Boussac M; French National Health Insurance (CNAM), Paris, France. Pacquement H; SIREDO Center (Care, Research, Innovation in Pediatric, Adolescents and Young Adults Oncology), Institut Curie, Paris, France. Doz F; SIREDO Center (Care, Research, Innovation in Pediatric, Adolescents and Young Adults Oncology), Institut Curie, Paris, France.; University Paris Cité, Paris, France. Berchery D; Epidemiology Unit, Claudius Regaud Institute, Toulouse, France. Pluchart C; Centre Hospitalier Universitaire de Reims, Pediatric Oncology, Reims, France. BondiauPY; Radiation Therapy, Antoine Lacassagne Cancer Center, Nice, France. Nys J; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Jackson A; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Demoor-Goldschmidt C; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Pediatric Oncology, CHU Angers, Angers, France.; Department of Radiotherapy and Department of Supportive Care, François Baclesse Center, Caen, France. Dumas A; Université Paris Cité, Inserm, ECEVE, UMR 1123, Paris, France. Thomas-Teinturier C; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Bicêtre Hospital, Service d'Endocrinologie et Diabétologie Pédiatrique AP-HP Université Paris Saclay, Paris, France. Schwartz B; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Journy N; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Rubino C; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Vu-Bezin G; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Valteau-Couanet D; Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, France. El-Fayech C; Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, France. Dufour C; Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, France. Haddy N; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. de Vathaire F; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France. .; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France. .; Department of Research, Gustave Roussy, Villejuif, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Oct 27; Vol. 12 (1), pp. 18068. Date of Electronic Publication: 2022 Oct 27.
Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM).
Autorzy:
Bejarano-Quisoboni D; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Primary care and Prevention Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Pelletier-Fleury N; Primary care and Prevention Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France. Allodji RS; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Lacour B; EPICEA, CRESS, INSERM UMR 1153, Université de Paris, Paris, France.; Registre National des Tumeurs Solides de l'Enfant, CHRU Nancy, Vandoeuvre-lès-Nancy, France. GrosClaude P; INSERM U1027, Toulouse, France. Pacquement H; SIREDO Center (Care, Research, Innovation in Pediatric, Adolescents and Young Adults Oncology), Institut Curie, Paris, France. Doz F; SIREDO Center (Care, Research, Innovation in Pediatric, Adolescents and Young Adults Oncology), Institut Curie, Paris, France.; University of Paris, Paris, France. Berchery D; Epidemiology Unit, Claudius Regaud Institute, Toulouse, France. Pluchart C; Pediatric Oncology, Reims, France. BondiauPY; Radiation Therapy, Antoine Lacassagne Cancer Center, Nice, France. Nys J; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Jackson A; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Demoor-Goldschmidt C; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; CHU Angers, Angers, France. Dumas A; Université de Paris, ECEVE, UMR1123, Inserm, Paris, France. Thomas-Teinturier C; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Service d'Endocrinologie et Diabétologie Pédiatrique AP-HP, Université Paris Saclay, Gif-sur-Yvette, France. Vu-Bezin G; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Valteau-Couanet D; Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, Paris, France. Haddy N; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France. Fresneau B; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, Paris, France. de Vathaire F; Radiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.; Université Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France.; Department of Research, Gustave Roussy, Villejuif, France.
Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Autorzy:
Li G; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, 510095, P. R. China. Xia YF; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong, 510060, P. R. China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. Huang YX; Department of Health Management, Public Health Institute of Sun Yat-sen University, Guangzhou, Guangdong, 510000, P. R. China. Okat D; Department of Finance, Hong Kong University of Science and Technology, Kowloon, Hong Kong, P. R. China. Qiu B; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong, 510060, P. R. China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. Doyen J; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06189, Nice, France.; Mediterranean Institute of Proton Therapy, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06200, Nice, France. BondiauPY; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06189, Nice, France.; Mediterranean Institute of Proton Therapy, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06200, Nice, France. Benezery K; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06189, Nice, France.; Mediterranean Institute of Proton Therapy, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06200, Nice, France. Gao J; Department of Radiation Oncology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, P. R. China. Qian CN; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong, 510060, P. R. China. .; Department of Radiation Oncology, Guangzhou Concord Cancer Center, Guangzhou, Guangdong, 510045, P. R. China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Aug 21; Vol. 21 (1), pp. 944. Date of Electronic Publication: 2021 Aug 21.
Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Autorzy:
Li G; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, 510095, P. R. China. Qiu B; State Key Laboratory of Oncology in South China, 651 Dongfeng East Road, Guangzhou, Guangdong, 510060, P. R. China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. Huang YX; Department of Health Management, Public Health Institute of Sun Yat-sen University, Guangzhou, Guangdong, 510000, P. R. China. Doyen J; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06189, Nice, France.; Mediterranean Institute of Proton Therapy, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06200, Nice, France. BondiauPY; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06189, Nice, France.; Mediterranean Institute of Proton Therapy, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06200, Nice, France. Benezery K; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06189, Nice, France.; Mediterranean Institute of Proton Therapy, Antoine Lacassagne Cancer Center, University of Nice-Sophia, 06200, Nice, France. Xia YF; State Key Laboratory of Oncology in South China, 651 Dongfeng East Road, Guangzhou, Guangdong, 510060, P. R. China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China. Qian CN; State Key Laboratory of Oncology in South China, 651 Dongfeng East Road, Guangzhou, Guangdong, 510060, P. R. China. .; Department of Radiation Oncology, Guangzhou Concord Cancer Center, Guangzhou, Guangdong, 510045, P. R. China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Jun 26; Vol. 20 (1), pp. 599. Date of Electronic Publication: 2020 Jun 26.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies